Strata Critical holder owns 7.9M shares, 9% stake
Strata Critical Medical, Inc. (SRTA) received an Amendment No. 3 to a Schedule 13G from Steele ExpCo Holdings, LLC, KSL Capital Partners V GP, LLC and Eric Charles Resnick reporting their ownership of Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Strata Critical Medical, Inc. (SRTA) received an Amendment No. 3 to a Schedule 13G from Steele ExpCo Holdings, LLC, KSL Capital Partners V GP, LLC and Eric Charles Resnick reporting their ownership of Class A Common Stock. The reporting group beneficially owns 7,923,000 shares of Class A Common Stock, representing 9.0% of the class, based on 88,466,806 shares outstanding as of July 28, 2026. These shares are held directly by Steele ExpCo Holdings, LLC, with KSL Capital Partners V GP, LLC as its managing member and Eric Charles Resnick as managing member of that entity, so they may be deemed to share voting and dispositive power over these shares. The amendment notes that on May 7, 2026, 4,500,000 warrants to purchase Class A Common Stock held by Steele ExpCo Holdings, LLC expired in accordance with their terms.
Key Figures
Key Terms
beneficially own financial
Rule 13d-3 regulatory
warrants financial
dispositive power financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in SRTA does Steele ExpCo Holdings report in this Schedule 13G/A?
Who are the reporting persons in this SRTA Schedule 13G/A amendment?
What change regarding warrants is disclosed for SRTA in this filing?
How is the 9.0% ownership in SRTA calculated in this Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.